ARG1 and hepatocellular carcinoma: In this study, by investigating the association between pre-treatment plasma ARG1 levels and early TACE refractoriness in patients with HCC, we aimed to identify patients who may show TACE refractoriness by developing a novel plasma ARG1-based nomogram.